A phase III study of S-1 plus cisplatin versus fluorouracil plus cisplatin in patients with advanced gastric or gastroesophageal junction adenocarcinoma

被引：1
|
作者：
Xu, Rui-hua
Sun, Guo-ping
Lu, Hui-shan
Peng, Liu Yun
Xu, Jian-ming
Zhong, Mei-zuo
Zhang, He-long
Yu, Shi-ying
Li, Wei
Hu, Xiao-hua
Wang, Jie Jun
Cheng, Ying
Zhou, Jun-tian
Guo, Zeng-qing
Guan, Zhongzhen
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
[2] An Hui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
[3] Fujian Med Univ, Union Hosp, Dept Surg Oncol, Shanghai, Peoples R China
[4] China Med Univ, Hosp 1, Shenyang, Peoples R China
[5] Chinese Peoples Liberat Army 307 Hosp, Dept Oncol, Beijing, Peoples R China
[6] Central South Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China
[7] Fourth Liberat Army Univ, Tangdu Hosp, Dept Oncol, Xian, Peoples R China
[8] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430074, Peoples R China
[9] Jilin Univ, Affiliated Hosp 1, Dept Oncol, Changchun, Jilin, Peoples R China
[10] Guangxi Zhuang Autonomous Reg Tumor Hosp, Dept Oncol, Nanning, Peoples R China
[11] Shanghai Chong Zhen Hosp, Shanghai, Peoples R China
[12] Jilin Prov Canc Hosp, Changchun, Peoples R China
[13] Tumor Hosp Hunan Prov, Dept Oncol, Changsha, Hunan, Peoples R China
[14] Tumor Hosp Fujian Prov, Dept Oncol, Fuzhou, Peoples R China
[15] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4025
引用
收藏
页数：1
相关论文
共 50 条
  • [1] S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
    Li, Yuhong
    Qiu, Miaozhen
    Xu, Jianming
    Sun, Guoping
    Lu, Huishan
    Liu, Yunpeng
    Zhong, Meizuo
    Zhang, Helong
    Yu, Shiying
    Li, Wei
    Hu, Xiaohua
    Wang, Jiejun
    Cheng, Ying
    Zhou, Juntian
    Guo, Zengqing
    Guan, Zhongzhen
    Xu, Ruihua
    ONCOTARGET, 2015, 6 (33) : 35107 - 35115
  • [2] Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma
    Ajani, JA
    Lec, FC
    Singh, DA
    Haller, DG
    Lenz, HJ
    Benson, AB
    Yanagilhara, R
    Phan, AT
    Yao, JC
    Strumberg, D
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 663 - 667
  • [3] Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
    Ajani, Jaffer A.
    Rodriguez, Wuilbert
    Bodoky, Gyorgy
    Moiseyenko, Vladimir
    Lichinitser, Mikhail
    Gorbunova, Vera
    Vynnychenko, Ihor
    Garin, August
    Lang, Istvan
    Falcon, Silvia
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1547 - 1553
  • [4] Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer
    Yamada, Y.
    Higuchi, K.
    Nishikawa, K.
    Gotoh, M.
    Fuse, N.
    Sugimoto, N.
    Nishina, T.
    Amagai, K.
    Chin, K.
    Niwa, Y.
    Tsuji, A.
    Imamura, H.
    Tsuda, M.
    Yasui, H.
    Fujii, H.
    Yamaguchi, K.
    Yasui, H.
    Hironaka, S.
    Shimada, K.
    Miwa, H.
    Hamada, C.
    Hyodo, I.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 141 - 148
  • [5] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [6] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [7] Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma
    Ajani, JA
    Faust, J
    Ikeda, K
    Yao, JC
    Anbe, H
    Carr, KL
    Houghton, M
    Urrea, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6957 - 6965
  • [8] Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 study group
    Ajani, Jaffer A.
    Moiseyenko, Vladimir M.
    Tjulandin, Sergei
    Majlis, Alejandro
    Constenla, Manuel
    Boni, Corrado
    Rodrigues, Adriano
    Fodor, Miguel
    Chao, Yee
    Voznyi, Edouard
    Marabotti, Cindy
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3205 - 3209
  • [9] Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 study group
    Ajani, Jaffer A.
    Moiseyenko, Vladimir M.
    Tjulandin, Sergei
    Majlis, Alejandro
    Constenla, Manuel
    Boni, Corrado
    Rodrigues, Adriano
    Fodor, Miguel
    Chao, Yee
    Voznyi, Edouard
    Awad, Lucile
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3210 - 3216
  • [10] A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer
    Kohei Shitara
    Akira Sawaki
    Keitaro Matsuo
    Chihiro Kondo
    Daisuke Takahari
    Takashi Ura
    Masahiro Tajika
    Yasumasa Niwa
    Kei Muro
    International Journal of Clinical Oncology, 2013, 18 : 539 - 546
12345